[{"AccountsPayableCurrent_0_Q1_USD":3648000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":3695000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":122000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":1175000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":4188000.0,"IncreaseDecreaseInPrepaidRent_1_Q1_USD":689000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-4872000.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_1_Q1_USD":-4464000.0,"ContractWithCustomerAssetNetCurrent_0_Q1_USD":742000.0,"ShortTermInvestments_0_Q1_USD":71517000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":56837000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":258826000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":9.73,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-80000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":12800000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":3591000.0,"DeferredRentCreditNoncurrent_0_Q1_USD":8667000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-19195000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":534218000.0,"OtherAssetsNoncurrent_0_Q1_USD":2246000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":55000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":310661000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":310606000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":328500000.0,"RestrictedCashNoncurrent_0_Q1_USD":1874000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":29399000.0,"PaymentsToAcquireMachineryAndEquipment_1_Q1_USD":565000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q1_USD":0.0,"OtherNoncashIncomeExpense_1_Q1_USD":-120000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-80000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q1_USD":3764000.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q1_USD":-100000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q1_USD":5141000.0,"InterestBearingDepositsInBanks_0_Q1_USD":17900000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q1_USD":0.0,"DeferredRentCreditCurrent_0_Q1_USD":2865000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_0_Q1_Security":4.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":4872000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":11354000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":3026000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q1_USD":5294000.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q1_USD":5455000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q1_USD":19654000.0,"NetIncomeLoss_1_Q1_USD":-19115000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-19110000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":26873000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":3591000.0,"LiabilitiesCurrent_0_Q1_USD":28462000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":360701000.0,"Liabilities_0_Q1_USD":41729000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":2005000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-5343000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":9096000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":6595000.0,"Depreciation_1_Q1_USD":1731000.0,"CommonStockValue_0_Q1_USD":68000.0,"CommonStockSharesOutstanding_0_Q1_shares":67936438.0,"CommonStockSharesIssued_0_Q1_shares":67936438.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":256952000.0,"AssetsCurrent_0_Q1_USD":338307000.0,"Assets_0_Q1_USD":360701000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":11220394.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-55000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.28,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":24364000.0,"ProfitLoss_1_Q1_USD":-19115000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-215259000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":380000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":18761810.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":49760000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":31486000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":3591000.0,"ShareBasedCompensation_1_Q1_USD":3695000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":38439000.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":18274000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":-20670000.0,"OperatingExpenses_1_Q1_USD":45034000.0,"CommonStockSharesAuthorized_0_Q1_shares":400000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":21949000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":67396229.0,"StockholdersEquity_0_Q1_USD":318972000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_0_Q1_shares":53437.0,"Ticker":"NGM","CIK":"1426332","name":"NGM BIOPHARMACEUTICALS INC","OfficialName":"NGM Biopharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1227500649.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200513"}]